The journey is the conversation.
We’re here for everyone who is affected by cancer. We help people find reliable answers to questions about their disease, support, and life beyond cancer.
April 15, 2024 • Views: 110
First Patient Dosed in TCR-NK Cell Therapy Trial for Multiple Myeloma
April 12, 2024 • Views: 6
Study: Black Patients at Greater Risk of Venous Thromboembolism Following Lung Cancer Surgery
April 9, 2024 • Views: 12
ICYMI: First Patient Dosed in Phase 2 Study for Metastatic RAS-Mutated Colorectal Cancer
April 8, 2024 • Views: 105
Princess Catherine’s Cancer Diagnosis is Part of a Disturbing Statistic
Breast Cancer • Cancer • Metastatic Breast Cancer
April 5, 2024 • Views: 12
When a Loved One Has Terminal Cancer, What Do You Say and How Do You Say it?
April 4, 2024 • Views: 12
Colorectal Cancer Tumors with Fusobacterium Nucleatum C2 Have Worse Outcomes
April 3, 2024 • Views: 11
ICYMI: Ocifisertib Earns Orphan Drug Designation for Acute Myeloid Leukemia
Chronic Myelomonocytic Leukemia
March 18, 2024 • Views: 21
IO-202 for Chronic Myelomonocytic Leukemia (CMML) Earns Orphan Drug Designation
Most Popular
Popular posts:
- Rare Black History: A Childhood Home of Rare Disease… August 31, 2023
- Study of the Week: New Method for Personalizing Head… April 17, 2023
- Mantle Cell Lymphoma: Not Yet Curable, But This… March 1, 2023
- New Investigative Therapy Could Drastically Minimize… March 1, 2023
Share Your Story
Are you a patient or caregiver with a passion to help others and tell your story? Sign up to learn more about this opportunity!
We’re here for everyone who is affected by cancer. We help people find reliable answers to questions about their disease, support, and life beyond cancer.
Let's Work Together
Site Map
- Home
- Contact Us
- Terms of Use
- Privacy Policy
- Privacy Notice for California Residents
- EU Privacy Notice
- Privacy Shield Policy
Recent from the Community